ArticleMemorias do Instituto Oswaldo Cruz2017

Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).

Lucia Regina Brahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.